Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons prof. dr. P. (Peter) van der Meer

Publicaties

Association between body mass index and clinical outcomes in patients with acute myocardial infarction and reduced systolic function: Analysis of PARADISE-MI trial data

Bromocriptine treatment and outcomes in peripartum cardiomyopathy: the EORP PPCM registry

Cardiovascular Safety in Oncology Clinical Trials: JACC: CardioOncology Primer

Discharge Medication After Natriuresis-Guided Dosing of Diuretic Therapy in Patients Hospitalized for Acute Heart Failure: A PUSH-AHF Substudy

Empagliflozin in acute myocardial infarction in patients with and without type 2 diabetes: A pre-specified analysis of the EMPACT-MI trial

Identification of disease-specific pathways and modifiers in phospholamban R14del cardiomyopathy: rationale, design and baseline characteristics of DECIPHER-PLN cohort

Liberal fluid intake versus fluid restriction in chronic heart failure: a randomized clinical trial

Micronutrient deficiencies and new-onset atrial fibrillation in a community-based cohort: Data from PREVEND

Mortality after high-risk myocardial infarction over the last 20 years: Insights from the VALIANT and PARADISE-MI trials

Multigene panel analysis has limited additional value compared to transthyretin gene analysis in Dutch patients with suspected cardiac amyloidosis

Pers/media

ESC 2022 Gesprek van de dag | zaterdag

Gebruik van kaliumbinders in de klinische praktijk

Behandeling van hartfalen nu en in de toekomst

Niet-cardiale comorbiditeiten bij hartfalen

Gain-of-function mutation in ubiquitin ligase KLHL24 causes desmin degradation and dilatation in hiPSC-derived engineered heart tissues

Ijzerdeficiëntie bij hartfalen - doe mee aan de poll

Intraveneus ijzer bij patiënten met ijzerdeficiëntie, gestabiliseerd na acuut HF

Ziekenhuizen: geef ons personeel direct het vaccin

Hoe diagnosticeer en behandel je amyloïdose?